Imipenem-Relebactam Susceptibility in Enterobacterales Isolates Recovered from ICU Patients from Spain and Portugal (SUPERIOR and STEP Studies)
Open Access
- 26 October 2022
- journal article
- research article
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 10 (5) , e0292722
Abstract
We comparatively evaluate the in vitro activity of a drug combination consisting of a carbapenem (imipenem) and a novel inhibitor of beta-lactamases (relebactam), a mechanism that destroys beta-lactam antibiotics. We assess the activity against a collection of Enterobacterales clinical isolates recovered from difficult-to-treat infections in patients admitted to different intensive care units in Portugal and Spain.Keywords
Funding Information
- MEC | Instituto de Salud Carlos III (CB21/13/00084)
This publication has 28 references indexed in Scilit:
- Emergence of Ceftazidime-Avibactam Resistance Due to Plasmid-Borne bla KPC-3 Mutations during Treatment of Carbapenem-Resistant Klebsiella pneumoniae InfectionsAntimicrobial Agents and Chemotherapy, 2017
- Phase 2, Dose-Ranging Study of Relebactam with Imipenem-Cilastatin in Subjects with Complicated Intra-abdominal InfectionAntimicrobial Agents and Chemotherapy, 2016
- The global epidemiology of carbapenemase-producing EnterobacteriaceaeVirulence, 2016
- β-Lactams and β-Lactamase Inhibitors: An OverviewCold Spring Harbor Perspectives in Medicine, 2016
- Predominance of KPC-3 in a Survey for Carbapenemase-Producing Enterobacteriaceae in PortugalAntimicrobial Agents and Chemotherapy, 2015
- Activity of MK-7655 combined with imipenem against Enterobacteriaceae and Pseudomonas aeruginosaJournal of Antimicrobial Chemotherapy, 2013
- Rapid evolution and spread of carbapenemases among Enterobacteriaceae in EuropeClinical Microbiology and Infection, 2012
- OXA-48-like carbapenemases: the phantom menaceJournal of Antimicrobial Chemotherapy, 2012
- Clinical outcomes of health-care-associated infections and antimicrobial resistance in patients admitted to European intensive-care units: a cohort studyThe Lancet Infectious Diseases, 2011
- Updated Functional Classification of β-LactamasesAntimicrobial Agents and Chemotherapy, 2010